How Health Economics Drives Medtech Growth with Christian Howell, CEO of Cognito Therapeutics

About this episode

Christian Howell discusses the advancements in non-invasive Alzheimer's therapy and the importance of evidence strategy in healthcare.

A non-invasive Alzheimer’s therapy is moving closer to patients, and it could reshape how brain health is treated. In this episode, Christian Howell, CEO of Cognito Therapeutics, joins Saul live at DeviceTalks Boston to discuss how the company is advancing a novel Alzheimer’s therapy that uses sensory stimulation through light, sound, and touch. He shares insights from Cognito’s HOPE study, the largest non-pharmacologic clinical trial in neurodegenerative disease, involving 673 participants across 70 sites. Christian explains why a strong evidence strategy is essential not only for regulatory approval but also for reimbursement, clinical adoption, and patient access. He also reflects on leadership lessons centered on service, humility, humor, and the importance of aligning stakeholders across the healthcare ecosystem to improve Alzheimer’s care. Tune in to hear how Christian Howell and Cognito Therapeutics are working to bring new hope, stronger evidence, and a more accessible path forward for Alzheimer’s patients and families! Resources: Connect with and follow Christian Howell on LinkedIn. Follow Cognito Therapeutics on LinkedIn and explore their website.

People in this episode

Host: Saul Marquez

Guest: Christian Howell

Topics covered

• Alzheimer's therapy
• health economics
• medtech growth
• clinical trials
• neurodegenerative disease
• patient access

Keywords

• Alzheimer's
• Cognito Therapeutics
• HOPE study
• clinical trial
• neurodegenerative disease
• healthcare leadership
• patient access

Mentioned in this episode

Organizations: Cognito Therapeutics

Places: Alzheimer’s

More episodes of Outcomes Rocket

• How Health Economics Drives Medtech Growth with Betty Tsai, President of Cardiology Services International · June 9, 2026 · 12 min
• From One Event to a Global Platform: The Rise of MedTech World with Dr. Dylan Attard, CEO and Co-founder of MedTech World · June 4, 2026 · 9 min
• Building a scalable pharma launch engine that drives competitive advantage with Lumanity’s Business Development Director, Jeff Hart, and Launch Excellence Principal, Kirsty Tait · June 2, 2026 · 26 min
• Reinventing Blood Testing for Better Patient Experience with Web Golinkin, President at Babson Diagnostics · May 28, 2026 · 22 min
• From Innovation to Adoption: What It Really Takes to Win in Medtech with Ken Nelson, Partner and Founder at Nelson Jennings Ventures · May 28, 2026 · 7 min
• Shifting from Denial Management to Denial Prevention with Jason Considine, President of Experian Health · May 27, 2026 · 22 min